Barriers to HIV Cure

被引:21
|
作者
Stein, J. [1 ]
Bonsmann, M. Storcksdieck Genannt [1 ]
Streeck, H. [1 ,2 ]
机构
[1] Univ Duisburg Essen, Univ Hosp Essen, Inst HIV Res, Essen, Germany
[2] Henry M Jackson Fdn, US Mil HIV Res Program, Rockville, MD USA
关键词
cellular barriers; HIV; immunological barriers; SIMIAN IMMUNODEFICIENCY VIRUS; T FOLLICULAR HELPER; ACTIVE ANTIRETROVIRAL THERAPY; CENTRAL-NERVOUS-SYSTEM; INFECTED PATIENTS; POSTEXPOSURE PROPHYLAXIS; CONTROLLED-TRIAL; VIRAL RESERVOIR; IMMUNE FUNCTION; CELL DEPLETION;
D O I
10.1111/tan.12867
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Since the beginning of the epidemic, more than 70 million people have been infected with human immunodeficiency virus (HIV) and about 38 million have died from acquired immune deficiency syndrome (AIDS)-related illnesses. While the discovery of highly active antiretroviral therapy (HAART) in the mid 90' s has saved millions of lives, a complete eradication of HIV is still not possible as HIV can persist for decades in a small reservoir of latently infected cells. Once reactivated, these latently infected cells can actively produce viral particles. Recent studies suggest that several sanctuaries exist within infected individuals where HIV can remain undetected by the immune system. These cellular, anatomical and microanatomical viral reservoirs represent a major obstacle for the eradication of HIV. Here we review recent findings on potential sanctuaries of HIV and address potential avenues to overcome these immunological barriers.
引用
收藏
页码:155 / 163
页数:9
相关论文
共 50 条
  • [31] Lifelong antiretroviral therapy or HIV cure: The benefits for the individual patient
    Buell, Kevin G.
    Chung, Christopher
    Chaudhry, Zain
    Puri, Aiysha
    Nawab, Khizr
    Ravindran, Rahul Prashanth
    AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV, 2016, 28 (02): : 242 - 246
  • [32] Barriers and facilitators to patient retention in HIV care
    Yehia, Baligh R.
    Stewart, Leslie
    Momplaisir, Florence
    Mody, Aaloke
    Holtzman, Carol W.
    Jacobs, Lisa M.
    Hines, Janet
    Mounzer, Karam
    Glanz, Karen
    Metlay, Joshua P.
    Shea, Judy A.
    BMC INFECTIOUS DISEASES, 2015, 15
  • [33] A novel anti-HIV immunotherapy to cure HIV
    Ahmad, Ali
    Rinaldo, Charles R.
    AIDS, 2017, 31 (03) : 447 - 449
  • [34] Pharmacology of HIV Cure: Site of Action
    Devanathan, Aaron S.
    Cottrell, Mackenzie L.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2021, 109 (04) : 841 - 855
  • [35] How Might We Cure HIV?
    David M. Margolis
    Current Infectious Disease Reports, 2014, 16
  • [36] Editorial: Immunotherapies Towards HIV Cure
    Salgado, Maria
    Bosque, Alberto
    Garrido, Carolina
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2021, 11
  • [37] Functional cure of HIV: the scale of the challenge
    Davenport, Miles P.
    Khoury, David S.
    Cromer, Deborah
    Lewin, Sharon R.
    Kelleher, Anthony D.
    Kent, Stephen J.
    NATURE REVIEWS IMMUNOLOGY, 2019, 19 (01) : 45 - 54
  • [38] Immunotherapeutic approaches to HIV cure and remission
    Lee, Ming J.
    Fidler, S.
    Frater, John
    CURRENT OPINION IN INFECTIOUS DISEASES, 2022, 35 (01) : 31 - 41
  • [39] Tools for Visualizing HIV in Cure Research
    Julia Niessl
    Amy E. Baxter
    Daniel E. Kaufmann
    Current HIV/AIDS Reports, 2018, 15 : 39 - 48
  • [40] Could gene therapy cure HIV?
    Sheykhhasan, Mohsen
    Foroutan, Aidin
    Manoochehri, Hamed
    Khoei, Saeideh Gholamzadeh
    Poondla, Naresh
    Saidijam, Massoud
    LIFE SCIENCES, 2021, 277